Concepedia

Ronald D. Hart

RD

Statistics

Publications

11

Citations

1.7K

H-Index

11

Active since

1978

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Dana-Farber Cancer Institute

Duke Medical Center

City University of New York

Memorial Sloan Kettering Cancer Center

Ronald D. Hart is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and chemotherapy.

Publications per year

1978–2019

11

Publications

11

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

W. C. Wood, Ronald D. Hart, Anne Moore et al. · New England Journal of Medicine · 1994 · 582 citations · Full text

, , +10

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

Hyman B. Muss, Donald A. Berry, Constance Cirrincione et al. · New England Journal of Medicine · 2009 · 559 citations · Full text

, , +17

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2‐overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study

Harold J. Burstein, Aparna Keshaviah, Ari David Baron et al. · Cancer · 2007 · 212 citations

, , +14

Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.

Leonidas C. Platanias, Carole B. Miller, Rosemarie Mick et al. · Journal of Clinical Oncology · 1991 · 116 citations

, , +11

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

Hyman B. Muss, Mei‐Yin C. Polley, Donald A. Berry et al. · Journal of Clinical Oncology · 2019 · 78 citations · Full text

, , +16

1–5 of 11